InvestorsHub Logo
Post# of 253253
Next 10
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

Re: DewDiligence post# 102183

Monday, 08/23/2010 1:57:21 PM

Monday, August 23, 2010 1:57:21 PM

Post# of 253253

Rather than progressing to a phase-2b study that measures SVR, Roche is evidently running another small PK/safety study.




Are you suggesting they should have moved to 2B with Ritonavir boosting?

“I am a big believer in giving it all away and have always said that the best financial planning ends with bouncing the check to the undertaker.”


Mike Bloomberg

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.